Hydroxychloroquine: I-MASK+, Zelenko and McCullough Protocols

By Dr Frank Yap, M.D. -

Hydroxychloroquine and COVID-19

Hydroxychloroquine (HCQ) is not effective when used very late with high dosages over a long period (RECOVERY/SOLIDARITY), effectiveness improves with earlier usage and improved dosing. Early treatment consistently shows positive effects. Negative evaluations typically ignore treatment time, often focusing on a subset of late stage studies.

As of January 2022 there have been more than 30 studies of Hydroxychloroquine for early treatment with an overall average improvement of 64% as compared to the control groups.

Here’s a chart from c19early.com that shows that hydroxychloroquine performs better than ivermectin when given as early treatment in terms of risk reduction of dying from COVID-19:


The overall improvement for hydroxychloroquine is better than ivermectin (for early treatment); 74% vs 51% in terms of death rate. Crucial point to note is that hydroxychloroquine needs to be given 'early'. 

The difference in terms of effectiveness for hydroxychloroquine is distinctly different when given early vs late treatment (64% vs 20%), as shown in the summary chart below:


The evidence tracking on Hydroxychloroquine for COVID-19 is available at c19hcq.com (constantly updated). 

Hydroxychloroquine, I-MASK+, Zelenko and McCullough Protocols

Hydroxychloroquine is also part of various early treatment protocols including the latest FLCCC I-MASK+ protocol, Zelenko protocol and Peter McCullough protocol. 

I-MASK protocol and hydroxychloroquine


Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (2023)

By Dr Frank Yap, M.D. -
Image
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough et al. Reviews in Cardiovascular Medicine, 2020 McCullough Protocol 2022 Note and Update: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious
Read more

The Wellness Company's Nattokinase Based Supplement: Spike Support Review 2023

By Dr Frank Yap, M.D. -
Image
Long after the mask mandates, the shut downs and vaccine requirements are little more than a distant memory, the legacy of COVID-19 and the COVID-19 vaccines will continue to haunt us in the form of spike protein. Loss of taste, sleeplessness, low energy – Millions of Americans are needlessly suffering from the long-term effects of COVID19. What’s worse, these symptoms may be magnified if you were vaccinated. Dr. McCullough was one of the most outspoken and bravest leaders during the pandemic, and today he is continuing his work to keep Americans healthy and safe in this new post-pandemic era of spike protein. https://covid19.onedaymd.com/2023/03/dr-peter-mccullough-prescription-and.html Dr. McCullough writes that, Over three years into the pandemic with nearly the entire country having become sick with SARS-CoV-2, a virus engineered to invade the body, there are millions suffering with long-hauler syndrome. Approximately half of patients admitted to the ICU with COVID-19 will have pos
Read more

Dr Peter McCullough Early Treatment Protocol (2023)

By Dr Frank Yap, M.D. -
Image
Well-respected North Texas cardiologist, Dr. Peter McCullough has impeccable academic credentials. He's an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough et al. Reviews in Cardiovascular Medicine, 2020 McCullough Protocol 2022 Note and Update: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) As published in Dr Peter McCullough's substack (Oct
Read more

America's Frontline Doctors Early Treatment Protocol and Contact a Physician 2023

By Dr Frank Yap, M.D. -
Image
  SELF-HELP without a Doctor ( source ) Zinc  50 mg daily (can take half twice daily if upset stomach) Quercetin  500 mg twice a day three times a day if sick (switch to HCQ/IVM if available) Vitamin D3  40,000-50,000 for five days Melatonin  5 mg - 20 mg nightly for 14 days stomach) Pepcid  40-80 daily 14 days – women or Cimetidine 400 daily -men Full Aspirin  (325 mg) daily one month N acetyl cysteine (NAC)  Up to 2000-2400 mg 1-2 days, then 1000-1200 mg for a week Treatment: Latest Prescriptions ( source ) Monoclonal Antibodies:  outpatient, FDA approved, early treatment, within 10 days Only. Note and Update: Omicron variant XBB found to be resistant to monoclonal antibody treatments ( New England Journal of Medicine . Dec 2022) HCQ  200 mg twice a day 7 days or IVM (weight based 0.4/kg) 20-36 mg daily 2-5 days Fenofibrate (Tricor – anti-lipid)  145 mg daily (inflammatory/cytokine phase. Antioxidant) Cyproheptadine (Periactin – antihistamine)  4 mg BID for 14 days (cytokine phase) D
Read more

How to Make Povidone Iodine 1% Nasal Spray

By Dr Frank Yap, M.D. -
Image
Is povidone iodine the next ivermectin or hydroxychloroquine? Is there any evidence that povidone iodine can treat COVID-19? Iodine 1% Nasal Spray is part of the FLCCC I-CARE early treatment protocol :  Nasal spray with 1% povidone-iodine: 2-3 times a day. Do not use for more than 5 days in pregnancy. If 1% product is not available, dilute the more widely available 10% solution and apply 4-5 drops to each nostril every 4 hours. Use 1 % povidone iodine commercial product as per instructions 2–3 x daily. If 1 %-product not available, must first dilute the more widely available 10 %-solution. To make 1% povidone iodine concentrated solution from 10% povidone iodine solution, one dilution method is as follows: – First pour 1½ tablespoons (25ml) of 10% povidone/ iodine solution into a nasal irrigation bottle of 250ml. – Then fill to top with distilled, sterile or previously boiled water. – Tilt head back, apply 4–5 drops to each nostril. Keep tilted for a few minutes, let drain. - Not recom
Read more

Find a Doctor to prescribe Paxlovid, Hydroxychloroquine, Ivermectin and Early Outpatient Treatments (2023)

By Dr Frank Yap, M.D. -
Image
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment.    To assist all who are having difficulty finding pharmacists to fill prescriptions for ivermectin or hydroxychloroquine (Plaquenil) for preventing or treating  COVID-19 , check out  Find a Pharmacy to fill Ivermectin  (US). See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA ​ MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID Treatment), I-RECOVER (Po
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2023)

By Dr Frank Yap, M.D. -
Image
Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Note that there are signif
Read more

FLCCC I-CARE COVID Treatment Protocol for Outpatients (2023)

By Dr Frank Yap, M.D. -
Image
Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. Update:   XBB.1.16 ‘Arcturus’ Is New Covid-19 Variant Under Monitoring By The WHO About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. New medications may be added and/or changes made to doses of existing medications as further evidence emerges. Please be sure you are using the latest version of this protocol. Update: T
Read more

Zero Young Healthy Individuals Died of COVID-19, Israeli Data Show

By Dr Frank Yap, M.D. -
Image
Zero healthy individuals under the age of 50 have died of COVID-19 in Israel, according to newly released data. “Zero deceased of 18–49 years of age with no underlying morbidities,” the Israel Ministry of Health (MOH) said in response to a formal request from an attorney. Officials noted that the statement only applies to COVID-19 deaths where the MOH conducted an epidemiological investigation and had received information about the underlying diseases. “Zero is a very, very clear number, and cannot be subject to interpretation,”   Yoav Yehezkelli , a specialist in internal medicine and medical management, and former lecturer in the Department of Emergency and Disaster Management at Tel Aviv University in Israel, told The Epoch Times. “Why were all the extreme measures of school closures, vaccination of children, and lockdowns needed?” he added. The MOH did respond to a request for comment. Freedom of Information Request The information was sparked by a freedom of information request fi
Read more

Increased Risk of Serious Eye Problem After COVID-19 Vaccination: Study

By Dr Frank Yap, M.D. -
Image
People who received a COVID-19 vaccine have an increased risk of a serious eye problem, according to a new study. The risk of retinal vascular occlusion “increased significantly” after a first or second dose of the messenger RNA (mRNA) COVID-19 vaccines, researchers reported in a study  published by Nature . The Pfizer and Moderna COVID-19 vaccines both use mRNA technology. Retinal vascular occlusion refers to the blockage of veins or vessels that carry blood to or from the retina. It can cause sudden vision loss. Out of 207,626 Pfizer vaccine doses administered in the population that was studied, 226 cases of the eye problem were detected after two years. Among 97,918 Moderna vaccine doses administered, 220 cases were detected over the same time. While some cases were detected among AstraZeneca recipients, the risk wasn’t statistically significant. The risk of retinal vascular occlusion was 3.5 times for vaccinated people compared to an unvaccinated group after 12 weeks and 2.19 times
Read more